Nabeel Khan (N Khan, Nabel Khan)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 30

Top Topics

Peritoneal Dialysis

Respiratory Syndrome Coronavirus

Patients With Inflammatory Bowel Disease

Ulcerative Colitis

Top Venues

Alimentary pharmacology & therapeutics

The American journal of gastroenterology

Crohn's & colitis 360

Clinical and translational gastroenterology

This page only lists publications with an associated author ORCID identifier.

Publications

Nabeel Khan, Ramaswamy Sundararajan, Manthankumar Patel, Chinmay Trivedi, Yu-Xiao Yang
Effectiveness of Tofacitinib in Patients With Ulcerative Colitis: A Nationwide Veterans Administration Cohort Study. The American journal of gastroenterology (2024)
Nabeel Khan, Ramaswamy Sundararajan, Manthankumar Patel, Chinmay Trivedi, Yu-Xiao Yang
Effectiveness of Tofacitinib in Patients With Ulcerative Colitis: A Nationwide Veterans Administration Cohort Study. The American journal of gastroenterology (2024)
Nabeel Khan, Ramaswamy Sundararajan, Manthankumar Patel, Chinmay Trivedi, Yu-Xiao Yang
Effectiveness of Tofacitinib in Patients With Ulcerative Colitis: A Nationwide Veterans Administration Cohort Study. The American journal of gastroenterology (2024)
Ramaswamy Sundararajan, Manthankumar Patel, Janak Bahirwani, Chinmay Trivedi, Nadim Mahmud, Nabeel Khan
Clinical Course of Bio Naive Ulcerative Colitis Patients Five Years After Initiation of Adalimumab in a Nationwide Cohort. Crohn's & colitis 360 6 (3) (2024)
Nabeel Khan, Ramaswamy Sundararajan, Manthankumar Patel, Chinmay Trivedi, Yu-Xiao Yang
Effectiveness Of Tofacitinib In Ulcerative Colitis Patients: A Nationwide Veterans Administration Cohort study. The American journal of gastroenterology (2024)
Ramaswamy Sundararajan, Manthankumar Patel, Janak Bahirwani, Chinmay Trivedi, Nadim Mahmud, Nabeel Khan
Clinical Course of Bio Naive Ulcerative Colitis Patients Five Years After Initiation of Adalimumab in a Nationwide Cohort. Crohn's & colitis 360 6 (3) (2024)
Nabeel Khan, Nadim Mahmud, Manthankumar Patel, Ramaswamy Sundararajan, Walter Reinisch
Risk of severe and opportunistic infections and the impact of SARS-COV-2 on this risk in a nationwide cohort of patients with inflammatory bowel disease. Alimentary pharmacology & therapeutics (2023)
Nabeel Khan, Nadim Mahmud, Manthankumar Patel, Ramaswamy Sundararajan, Walter Reinisch
Risk of severe and opportunistic infections and the impact of SARS-COV-2 on this risk in a nationwide cohort of patients with inflammatory bowel disease. Alimentary pharmacology & therapeutics 57 (7) (2023)
Nabeel Khan, Nadim Mahmud, Manthankumar Patel, Ramaswamy Sundararajan, Walter Reinisch
Risk of severe and opportunistic infections and the impact of SARS-COV-2 on this risk in a nationwide cohort of patients with inflammatory bowel disease. Alimentary pharmacology & therapeutics (2023)
Nabeel Khan, Nadim Mahmud, Manthankumar Patel, Ramaswamy Sundararajan, Walter Reinisch
Risk of severe and opportunistic infections and the impact of SARS-COV-2 on this risk in a nationwide cohort of patients with inflammatory bowel disease. Alimentary pharmacology & therapeutics 57 (7) (2023)
Nabeel Khan, Nadim Mahmud, Manthankumar Patel, Ramaswamy Sundararajan, Walter Reinisch
Risk of severe and opportunistic infections and the impact of SARS-COV-2 on this risk in a nationwide cohort of patients with inflammatory bowel disease. Alimentary pharmacology & therapeutics 57 (7) (2023)
Nabeel Khan, Nadim Mahmud, Manthankumar Patel, Ramaswamy Sundararajan, Walter Reinisch
Risk of severe and opportunistic infections and the impact of SARS-COV-2 on this risk in a nationwide cohort of patients with inflammatory bowel disease. Alimentary pharmacology & therapeutics 57 (7) (2023)
Nabeel Khan, Chinmay Trivedi, Yash Shah, Manthankumar Patel, Ramaswamy Sundararajan, Dawei Xie, Yu-Xiao Yang
Incidence of Pneumonia, Related Hospitalization, and Mortality Among Younger Unvaccinated IBD Patients in a Nationwide Cohort. Journal of clinical gastroenterology (2023)
Nadim Mahmud, Yash Shah, Nabeel Khan
Prevalence of SARS-COV-2 Vaccination and Factors Impacting Likelihood of Vaccination in a Nationwide Veterans Affairs Cohort of IBD Patients. Inflammatory bowel diseases 28 (11) (2022)
Helen Lee, Nabeel Khan
Editorial: effectiveness and safety of vedolizumab in a matched cohort of elderly and non-elderly patients with inflammatory bowel disease - the IG-IBD LIVE study. Alimentary pharmacology & therapeutics 56 (4) (2022)
Nadim Mahmud, Walter Reinisch, Manthankumar Patel, Ramaswamy Sundararajan, Nabeel Khan
ADVERSE EVENTS RELATED TO SARS-COV-2 VACCINE IN A NATIONWIDE COHORT OF INFLAMMATORY BOWEL DISEASE PATIENTS. Clinical and translational gastroenterology (2022)
Nadim Mahmud, Walter Reinisch, Manthankumar Patel, Ramaswamy Sundararajan, Nabeel Khan
ADVERSE EVENTS RELATED TO SARS-COV-2 VACCINE IN A NATIONWIDE COHORT OF INFLAMMATORY BOWEL DISEASE PATIENTS. Clinical and translational gastroenterology (2022)
Nabeel Khan, Nadim Mahmud
COVID-19 Vaccine Effectiveness Against the Omicron Variant in a Veterans Affairs Cohort of Patients With Inflammatory Bowel Disease. The American journal of gastroenterology (2022)
Nabeel Khan, Yu-Xiao Yang
Letter: screening for infectious side effects in patients with IBD-the importance and potential of real-world remote monitoring. Authors' reply. Alimentary pharmacology & therapeutics 55 (2) (2022)
Nabeel Khan, Chinmay Trivedi, Faten Aberra, Tyler Pernes, Yu-Xiao Yang
Safety of Recombinant Zoster Vaccine in Patients with Inflammatory Bowel Disease. Journal of Crohn's & colitis 16 (9) (2022)
Nadim Mahmud, Walter Reinisch, Manthankumar Patel, Ramaswamy Sundararajan, Nabeel Khan
ADVERSE EVENTS RELATED TO SARS-COV-2 VACCINE IN A NATIONWIDE COHORT OF INFLAMMATORY BOWEL DISEASE PATIENTS. Clinical and translational gastroenterology (2022)
Nabeel Khan, Nadim Mahmud
COVID-19 Vaccine Effectiveness Against the Omicron Variant in a Veterans Affairs Cohort of Patients With Inflammatory Bowel Disease. The American journal of gastroenterology (2022)
Nabeel Khan, Tyler Pernes, Alexandra Weiss, Chinmay Trivedi, Manthankumar Patel, Elina Medvedeva, Dawei Xie, Yu-Xiao Yang
Efficacy of Vedolizumab in a Nationwide Cohort of Elderly Inflammatory Bowel Disease Patients. Inflammatory bowel diseases (2021)
Nabeel Khan, Dhruvan Patel, Tyler Pernes, Manthankumar Patel, Chinmay Trivedi, Elina Medvedeva, Dawei Xie, Yu-Xiao Yang
The Efficacy and Safety of Switching From Originator Infliximab to Single or Double Switch Biosimilar Among a Nationwide Cohort of Inflammatory Bowel Disease Patients. Crohn's & colitis 360 3 (2) (2021)
Nabeel Khan, Dhruvan Patel, Tyler Pernes, Manthankumar Patel, Chinmay Trivedi, Elina Medvedeva, Dawei Xie, Yu-Xiao Yang
The Efficacy and Safety of Switching From Originator Infliximab to Single or Double Switch Biosimilar Among a Nationwide Cohort of Inflammatory Bowel Disease Patients. Crohn's & colitis 360 3 (2) (2021)
Nabeel Khan, Dhruvan Patel, Chinmay Trivedi, Tyler Pernes, Himanshu Kavani, Dawei Xie, Yu-Xiao Yang
The impact of IBD medications on risk of pneumonia and pneumonia-related hospitalisation: a nationwide cohort study of 56 410 IBD patients. Alimentary pharmacology & therapeutics (2021)
Nabeel Khan, Nadim Mahmud, Chinmay Trivedi, Walter Reinisch, James D Lewis
Risk factors for SARS-CoV-2 infection and course of COVID-19 disease in patients with IBD in the Veterans Affair Healthcare System. Gut 70 (9) (2021)
Nabeel Khan, Tyler Pernes, Alexandra Weiss, Chinmay Trivedi, Manthankumar Patel, Dawei Xie, Yu-Xiao Yang
Incidence of Infections and Malignancy Among Elderly Male Patients with IBD Exposed to Vedolizumab, Prednisone, and 5-ASA Medications: A Nationwide Retrospective Cohort Study. Advances in therapy 38 (5) (2021)
Nabeel Khan, James D Lewis
Letter: the safety of herpes zoster vaccination for patients with inflammatory bowel disease being treated with anti-TNF medications-authors' reply. Alimentary pharmacology & therapeutics 47 (3) (2019)
Nabeel Khan, Y Shah, C Trivedi, J D Lewis
Safety of herpes zoster vaccination among inflammatory bowel disease patients being treated with anti-TNF medications. Alimentary pharmacology & therapeutics 46 (7) (2017)